|
1
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Tejeda-Maldonado J, García-Juárez I,
Aguirre-Valadez J, González-Aguirre A, Vilatobá-Chapa M,
Armengol-Alonso A, Escobar-Penagos F, Torre A, Sánchez-Ávila JF and
Carrillo-Pérez DL: Diagnosis and treatment of hepatocellular
carcinoma: An update. World World J Hepatol. 7:362–376. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Chen G, Li X, He G, Yu Z, Luo J, He J and
Huang Z: Low expression of GNAI3 predicts poor prognosis in
patients with HCC. Int J Clin Exp Med. 8:21482–21486.
2015.PubMed/NCBI
|
|
5
|
Takayama T: Surgical treatment for
hepatocellular carcinoma. Jpn J Clin Oncol. 41:447–454. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Lau WY, Lai EC and Leung TW: Current role
of selective internal irradiation with yttrium-90 microspheres in
the management of hepatocellular carcinoma: A systematic review.
Int J Radiat Oncol Biol Phys. 81:460–467. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Niu ZS, Niu XJ and Wang WH: Genetic
alterations in hepatocellular carcinoma: An update. World J
Gastroenterol. 22:9069–9095. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
van Meer S, de Man RA, Siersema PD and van
Erpecum KJ: Surveillance for hepatocellular carcinoma in chronic
liver disease: Evidence and controversies. World J Gastroenterol.
19:6744–6756. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Morise Z, Kawabe N, Tomishige H, Nagata H,
Kawase J, Arakawa S, Yoshida R and Isetani M: Recent advances in
the surgical treatment of hepatocellular carcinoma. World J
Gastroenterol. 20:14381–14392. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Chen X, Liu HP, Li M and Qiao L: Advances
in non-surgical management of primary liver cancer. World J
Gastroenterol. 20:16630–16638. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Zeke A, Misheva M, Remenyi A and
Bogoyevitch MA: JNK Signaling: Regulation and functions based on
complex Protein-protein partnerships. Microbiol Mol Biol Rev.
80:793–835. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Cheng CW, Leong KW and Tse E:
Understanding the role of PIN1 in hepatocellular carcinoma. World J
Gastroenterol. 22:9921–9932. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zhang A, Yin C, Wang Z, Zhang Y, Zhao Y,
Li A, Sun H, Lin D and Li N: Development and application of a
fluorescence protein microarray for detecting serum
alpha-fetoprotein in patients with hepatocellular carcinoma. J Int
Med Res. 44:1414–1423. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Lok AS, Sterling RK, Everhart JE, Wright
EC, Hoefs JC, Di Bisceglie AM, Morgan TR, Kim HY, Lee WM, Bonkovsky
HL, et al: Des-gamma-carboxy prothrombin and alpha-fetoprotein as
biomarkers for the early detection of hepatocellular carcinoma.
Gastroenterology. 138:493–502. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zhang SY, Lin BD and Li BR: Evaluation of
the diagnostic value of alpha-l-fucosidase, alpha-fetoprotein and
thymidine kinase 1 with ROC and logistic regression for
hepatocellular carcinoma. FEBS Open Bio. 5:240–244. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Hepowit NL, de Vera IM, Cao S, Fu X, Wu Y,
Uthandi S, Chavarria NE, Englert M, Su D, Sӧll D, et al:
Mechanistic insight into protein modification and sulfur
mobilization activities of noncanonical E1 and associated
ubiquitin-like proteins of Archaea. FEBS J. 283:3567–3586. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Kim KI, Chung HK, Park JH, Lee YJ and Kang
JH: Alpha-fetoprotein-targeted reporter gene expression imaging in
hepatocellular carcinoma. World J Gastroenterol. 22:6127–6134.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zhou Y, Zhao Y, Gao Y, Hu W, Qu Y, Lou N,
Zhu Y, Zhang X and Yang H: Hepatitis C virus NS3 protein enhances
hepatocellular carcinoma cell invasion by promoting PPM1A
ubiquitination and degradation. J Exp Clin Cancer Res. 36:422017.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Weissman AM: Themes and variations on
ubiquitylation. Nat Rev Mol Cell Biol. 2:169–178. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Chen S, Wang DL, Liu Y, Zhao L and Sun FL:
RAD6 regulates the dosage of p53 by a combination of
transcriptional and posttranscriptional mechanisms. Mol Cell Biol.
32:576–587. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Lee KY and Myung K: PCNA modifications for
regulation of post-replication repair pathways. Mol Cells. 26:5–11.
2008.PubMed/NCBI
|
|
22
|
Cai F, Chen P, Chen L, Biskup E, Liu Y,
Chen PC, Chang JF, Jiang W, Jing Y, Chen Y, et al: Human RAD6
promotes G1-S transition and cell proliferation through
upregulation of cyclin D1 expression. PLoS One. 9:e1137272014.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Bergink S and Jentsch S: Principles of
ubiquitin and SUMO modifications in DNA repair. Nature.
458:461–467. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Shekhar MP, Lyakhovich A, Visscher DW,
Heng H and Kondrat N: Rad6 overexpression induces multinucleation,
centrosome amplification, abnormal mitosis, aneuploidy, and
transformation. Cancer Res. 62:2115–2124. 2002.PubMed/NCBI
|
|
25
|
European Association for the study of the
liver; European Organisation for Research and Treatment of Cancer:
EASL-EORTC clinical practice guidelines: Management of
hepatocellular carcinoma. J Hepatol. 56:908–943. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Zhou B, Yuan T, Liu M, Liu H, Xie J, Shen
Y and Chen P: Overexpression of the structural maintenance of
chromosome 4 protein is associated with tumor de-differentiation,
advanced stage and vascular invasion of primary liver cancer. Oncol
Rep. 28:1263–1268. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Edge SB and Compton CC: The American Joint
Committee on cancer: The 7th edition of the AJCC cancer staging
manual and the future of TNM. Ann Surg Oncol. 17:1471–1474. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Ni W, Zhang Y, Zhan Z, Ye F, Liang Y,
Huang J, Chen K, Chen L and Ding Y: A novel lncRNA uc.134 represses
hepatocellular carcinoma progression by inhibiting CUL4A-mediated
ubiquitination of LATS1. J Hematol Oncol. 10:912017. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Ju LL, Chen L, Li JH, Wang YF, Lu RJ, Bian
ZL and Shao JG: Effect of NDC80 in human hepatocellular carcinoma.
World J Gastroenterol. 23:3675–3683. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Wang X and Terpstra EJ: Ubiquitin
receptors and protein quality control. J Mol Cell Cardiol.
55:73–84. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Yamashita T, Kitao A, Matsui O, Hayashi T,
Nio K, Kondo M, Ohno N, Miyati T, Okada H, Yamashita T, et al:
Gd-EOB-DTPA-enhanced magnetic resonance imaging and
alpha-fetoprotein predict prognosis of early-stage hepatocellular
carcinoma. Hepatology. 60:1674–1685. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Quagliata L, Matter MS, Piscuoglio S,
Arabi L, Ruiz C, Procino A, Kovac M, Moretti F, Makowska Z,
Boldanova T, et al: Long noncoding RNA HOTTIP/HOXA13 expression is
associated with disease progression and predicts outcome in
hepatocellular carcinoma patients. Hepatology. 59:911–923. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Chen S, Wei HM, Lv WW, Wang DL and Sun FL:
E2 ligase dRad6 regulates DMP53 turnover in drosophila. J Biol
Chem. 286:9020–9030. 2011. View Article : Google Scholar : PubMed/NCBI
|
